By Will Feuer
Synthetic Biologics Inc. said it has set a 1-for-10 reverse stock split to ensure that the company can meet the per-share price requirements to remain listed on the NYSE American.
The stock will begin trading on a split-adjusted basis on July 25, the company said. The reverse stock split was authorized by the company's board on July 11. The number of outstanding common shares would be reduced to 15.8 million shares from 158.4 million shares.
The stock fell nearly 14%, to 20 cents a share, in premarket trading after the announcement.
Write to Will Feuer at Will.Feuer@wsj.com
$(END)$ Dow Jones Newswires
July 15, 2022 08:22 ET (12:22 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.